$INV

Innventure (INV) Q4 2025 Earnings Transcript

Innventure (INV) reported 2025 revenue of $2.1m vs. $1.2m in 2024, driven by Accelsius and AeroFlexx. Accelsius delivered $1.6m revenue (vs. $0.3m) and secured $50m+ in new Q1 bookings; Accelsius Series B closed at a ~$665m post-money valuation. Management expects Accelsius to be cash-flow positive by year-end. Cash rose to $65.4m; adjusted EBITDA loss was $78.8m.

Original reporting
Published May 27, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 10:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Innventure (INV) Q4 2025 Earnings Transcript — source image
Decision brief

The 30-second read

$INVBullishMed
01

Why it matters

The transcript highlights contracted backlog conversion progress (Accelsius), expanding commercial pipeline (AeroFlexx), and significant cost/liquidity improvements at the parent level, which together can drive a valuation re-rating if execution continues.

02

Market read

This is a small-cap earnings transcript with multiple near-term catalysts: contracted backlog growth, pipeline expansion, liquidity build, and a stated path to cash-flow positivity.

03

What to watch

Parent-level improvements may be partly accounting/structure-driven (operating companies raising capital independently); investors should watch whether bookings convert to recognized revenue and cash, not just contracted backlog.

Relevance 9/10Timing: Immediate (earnings transcript with Q1 2026 bookings and year-end cash-flow target).

Background

Innventure operates a platform of operating companies (notably Accelsius for liquid cooling and AeroFlexx for refill packaging), and the call emphasizes a transition toward commercial self-funding.

Company-level read

Ticker impact

$INVBullishMedium confidence
Context

Innventure reported 2025 revenue of $2.1M, disclosed $50M+ Accelsius bookings in Q1 2026, and guided toward cash-flow positivity by year-end.

Expected impact

Near-term upside bias as investors re-rate the backlog-to-revenue conversion and liquidity/cost trajectory; volatility possible given large adjusted EBITDA loss.

Evidence & confidence

The article provides concrete operating metrics (bookings, pipeline, cash, G&A reduction) and management targets, but lacks full financial guidance detail and includes a large adjusted EBITDA loss that can temper sentiment.

$JCIBullishLow confidence
Context

Johnson Controls led the $65M Accelsius Series B, valuing Accelsius at about $665M post-money and signaling strategic validation.

Expected impact

Limited direct impact expected on JCI given the investment is likely small relative to JCI’s scale, but could support sentiment among industrial/energy-efficiency investors.

Evidence & confidence

The article does not quantify JCI’s investment size beyond the round total, nor does it describe material revenue contribution to JCI.

Market effects

Supports the narrative of accelerating adoption for liquid cooling/data-center thermal management platforms via contracted production-scale deployments.

No explicit regional demand signal; impact is primarily US-listed small-cap growth/industrial tech sentiment.

Aveda global partnership and multinational CPG agreement suggest broader international commercialization pathways for refill/packaging tech.

Counterpoint

Despite $50M+ bookings, only a minority of AeroFlexx pipeline is in final contract stages and adjusted EBITDA remains deeply negative, leaving execution risk.

Key entities

  • Innventure

    Reported 2025 results, disclosed Accelsius bookings and valuation from Series B, and outlined cash-flow positivity expectations and cost/capital structure changes.

  • Accelsius

    Received $65M Series B with ~$665M post-money valuation; management expects cash-flow positive by year-end and targets ~$100M annualized revenue by December.

  • AeroFlexx

    Built a nearly $30M commercial pipeline with a global Aveda partnership and early-2027 rollout target for refill packaging.

  • Johnson Controls

    Led Accelsius’ Series B tranche, providing strategic validation for the platform’s cooling business.

  • Legrand

    Participated in Accelsius’ Series B, reinforcing investor confidence in the valuation and commercialization path.

Related articles

$INVMed

Innventure, Inc. (INV): Results of Operations and Financial Condition

Innventure, Inc. (INV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991innventure-2q26earning.htm EX-99.1 Document Exhibit 99.1 Innventure Reports Second Quarter 2026 Results Accelsius focused on execution against foundational milestones to strengthen path to scaled two-phase adoption ORLANDO, Fla., August 13, 2026 (GLOBAL NEWSWIRE) –

$JCIMed

Can Johnson Controls (JCI) Turn Wasted Heat Into $18B?

Johnson Controls (JCI) launched an Absorption Chiller Reference Design Guide to convert waste heat from on-site generators into cooling capacity for data centers. The company says it can cut cooling electricity demand up to 44% and support up to $18B in additional life revenue. Ahead of its July 29 fiscal Q3 2026 results, it reported $6.6B sales (+9%), organic sales +10%, orders +27% and backlog $21.0B (+32% organic), raising guidance.

$JCIMedAI 8/10

Johnson Controls Boosts FY26 Outlook; Stock Up 4% - Update

Johnson Controls International (JCI) reported Q3 results and raised its FY2026 outlook. For Q4, it expects adjusted EPS of about $1.55 and organic sales growth of 9% to 10%. For FY2026, it now projects adjusted EPS from continuing operations of about $5.05 on ~8% organic growth, versus prior $4.85 on ~6%. Shares were up about 4% premarket.

$JCIHighAI 9/10

Why is Johnson Controls stock surging today? By Investing.com

Investing.com reports Johnson Controls (JCI) shares rose about 5.6% in pre-open after fiscal Q3 2026 results beat expectations. Adjusted EPS was $1.42 vs ~$1.29-$1.30 consensus, and revenue was $6.60B vs ~$6.46-$6.47B. The company raised full-year 2026 adjusted EPS guidance to $5.05 and lifted its long-term organic growth target to high single digits.

$JCIMedAI 8/10

Johnson Controls (NYSE:JCI) Posts Better

Johnson Controls (NYSE:JCI) reported Q2 2026 results. Revenue rose 9.3% year over year to $6.61 billion, exceeding Wall Street estimates by 2.5%, and non-GAAP EPS was $1.42, up from $1.05 and about 9% above consensus. The company cited 10% organic revenue growth and margin expansion. Analysts expect full-year EPS to rise to $5.58.